콘텐츠로 건너뛰기
Merck

SLITRK6 mutations cause myopia and deafness in humans and mice.

The Journal of clinical investigation (2013-04-02)
Mustafa Tekin, Barry A Chioza, Yoshifumi Matsumoto, Oscar Diaz-Horta, Harold E Cross, Duygu Duman, Haris Kokotas, Heather L Moore-Barton, Kazuto Sakoori, Maya Ota, Yuri S Odaka, Joseph Foster, F Basak Cengiz, Suna Tokgoz-Yilmaz, Oya Tekeli, Maria Grigoriadou, Michael B Petersen, Ajith Sreekantan-Nair, Kay Gurtz, Xia-Juan Xia, Arti Pandya, Michael A Patton, Juan I Young, Jun Aruga, Andrew H Crosby
초록

Myopia is by far the most common human eye disorder that is known to have a clear, albeit poorly defined, heritable component. In this study, we describe an autosomal-recessive syndrome characterized by high myopia and sensorineural deafness. Our molecular investigation in 3 families led to the identification of 3 homozygous nonsense mutations (p.R181X, p.S297X, and p.Q414X) in SLIT and NTRK-like family, member 6 (SLITRK6), a leucine-rich repeat domain transmembrane protein. All 3 mutant SLITRK6 proteins displayed defective cell surface localization. High-resolution MRI of WT and Slitrk6-deficient mouse eyes revealed axial length increase in the mutant (the endophenotype of myopia). Additionally, mutant mice exhibited auditory function deficits that mirrored the human phenotype. Histological investigation of WT and Slitrk6-deficient mouse retinas in postnatal development indicated a delay in synaptogenesis in Slitrk6-deficient animals. Taken together, our results showed that SLITRK6 plays a crucial role in the development of normal hearing as well as vision in humans and in mice and that its disruption leads to a syndrome characterized by severe myopia and deafness.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Monoclonal Anti-Neurofilament 160 antibody produced in mouse, clone NN18, ascites fluid